We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Roche's Viracept Marketing Authorization Suspended Following Manufacturing Error
Roche's Viracept Marketing Authorization Suspended Following Manufacturing Error
July 2, 2007
The European Medicines Agency (EMEA) suspended the marketing authorization for Roche’s HIV treatment Viracept after a manufacturing error resulted in a recall of all batches of the product.